Clinical Safety

Could a Banned Diet Drug Safely Fight Obesity?
Research & Development Could a Banned Diet Drug Safely Fight Obesity?

A ghost from medicine's past, a chemical once notorious for its lethal side effects in the pursuit of weight loss, is being cautiously resurrected by scientists aiming to solve the modern obesity crisis. This ambitious endeavor revisits a century-old idewhat if a drug could make the human body

New 3D Maps Reveal The Human Genome's Hidden Architecture
Research & Development New 3D Maps Reveal The Human Genome's Hidden Architecture

Deep within the microscopic confines of every human cell, a biological masterpiece unfolds not as a simple string of code but as a dynamic, three-dimensional sculpture that dictates life itself. A landmark study has now provided the most detailed and extensive atlas of this hidden architecture,

Study Redefines Cancer Protein to Unlock Safer Drugs
Research & Development Study Redefines Cancer Protein to Unlock Safer Drugs

A promising class of anti-cancer drugs, designed with pinpoint precision to kill tumor cells, was abruptly sidelined by a mysterious and life-threatening side effect, leaving a potential breakthrough in oncology on the shelf. This clinical roadblock highlighted a fundamental challenge in modern

What If We Could See Exactly Where Drugs Work?
Research & Development What If We Could See Exactly Where Drugs Work?

The perplexing reality that a medication meticulously designed to target cancer cells in the lungs can unexpectedly trigger adverse reactions in the heart has long been one of pharmacology's most frustrating and dangerous puzzles. For decades, the path a drug takes after being administered has been

Will Patient Deaths Derail Merck's New Cancer Drug?
Research & Development Will Patient Deaths Derail Merck's New Cancer Drug?

The cutting edge of cancer treatment often involves a delicate and high-stakes balance between revolutionary efficacy and severe, sometimes fatal, side effects. This reality has been starkly highlighted as a pivotal late-stage clinical trial for a promising new cancer therapy, ifinatamab deruxtecan

Cheaper Health Plans Come With Hidden Risks
Research & Development Cheaper Health Plans Come With Hidden Risks

For millions of Americans navigating the annual health insurance marketplace, the stark reality of rising premiums forces a difficult calculation between financial solvency and physical well-being. This yearly ritual has become a high-stakes balancing act, where the allure of a lower monthly

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later